{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:28:54Z","timestamp":1792412934613,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000957","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T00:00:00Z","timestamp":1402358400000}}],"reference-count":46,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000957.pub2","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T05:36:39Z","timestamp":1402464999000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Methotrexate for treating rheumatoid arthritis"],"prefix":"10.1002","volume":"2014","author":[{"given":"Maria Angeles","family":"Lopez-Olivo","sequence":"first","affiliation":[{"name":"The University of Texas, M.D. Anderson Cancer Center; Department of General Internal Medicine; 1515 Holcombe Blvd Unit 1465 Houston Texas USA 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish R","family":"Siddhanamatha","sequence":"additional","affiliation":[{"name":"The University of Texas, M.D. Anderson Cancer Center; Department of General Internal Medicine; 1515 Holcombe Blvd Unit 1465 Houston Texas USA 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Shea","sequence":"additional","affiliation":[{"name":"University of Ottawa; Department of Epidemiology and Community Medicine; 501 Smyth Road Ottawa Ontario Canada K1H 8L6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tugwell","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ottawa; Department of Medicine; Ottawa Ontario Canada K1H 8M5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A","family":"Wells","sequence":"additional","affiliation":[{"name":"University of Ottawa; Department of Epidemiology and Community Medicine; 501 Smyth Road Ottawa Ontario Canada K1H 8L6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E","family":"Suarez-Almazor","sequence":"additional","affiliation":[{"name":"The University of Texas, M.D. Anderson Cancer Center; Department of General Internal Medicine; 1515 Holcombe Blvd Unit 1465 Houston Texas USA 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD000957.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7326\/0003-4819-103-4-489","article-title":"Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study","volume":"103","author":"Andersen","year":"1985","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD000957.pub2-BIB0002|cit2","first-page":"1628","article-title":"Adverse experience with methotrexate during 176 weeks of a long-term prospective trial in patients with rheumatoid arthritis","volume":"17","author":"Furst","year":"1990","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD000957.pub2-BIB0003|cit3","first-page":"313","article-title":"Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis","volume":"16","author":"Furst","year":"1989","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0004|cit4","first-page":"204","article-title":"Clinical effectiveness of methotrexate treatment in rheumatoid arthritis patients: a randomized controlled trial","volume":"4","author":"Jiang","year":"1998","journal-title":"Chinese Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD000957.pub2-BIB0005|cit5","first-page":"91","article-title":"[A short-term randomized controlled study with methotrexate in rheumatoid arthritis]. [Portuguese]","volume":"39","author":"Pinheiro","year":"1993","journal-title":"Revista Da Associacao Medica Brasileira"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/030097499750042263","article-title":"Leflonomide versus methotrexate: A comparison of the European and American experience","volume":"28 Suppl 112","author":"Schiff","year":"1999","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD000957.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/1529-0131(200003)43:3<495::AID-ANR4>3.0.CO;2-U","article-title":"Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group","volume":"43","author":"Sharp","year":"2000","journal-title":"Arthritis and Rheumatism"},{"issue":"21","key":"10.1002\/14651858.CD000957.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/archinte.159.21.2542","article-title":"Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group","volume":"159","author":"Strand","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD000957.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/1529-0131(199909)42:9<1870::AID-ANR11>3.0.CO;2-D","article-title":"Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group","volume":"42","author":"Strand","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0010|cit10","first-page":"506","article-title":"Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group","volume":"3","author":"Tugwell","journal-title":"Arthritis and Rheumatism"},{"issue":"13","key":"10.1002\/14651858.CD000957.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJM198503283121303","article-title":"Efficacy of low-dose methotrexate in rheumatoid arthritis","volume":"312","author":"Weinblatt","year":"1985","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000957.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/art.1780300213","article-title":"Lack of association between HLA-DR2 and clinical response to methotrexate in patients with rheumatoid arthritis","volume":"30","author":"Alarcon","year":"1987","journal-title":"Arthritis and Rheumatism"},{"issue":"150","key":"10.1002\/14651858.CD000957.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archinte.1990.00390130073009","article-title":"Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires","volume":"150","author":"Tugwell","year":"1990","journal-title":"Archives of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD000957.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/art.1780280702","article-title":"Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial","volume":"28","author":"Williams","year":"1985","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/03009749009102535","article-title":"Clinical and laboratory outcomes during the treatment of rheumatoid arthritis with methotrexate","volume":"19","author":"Cannon","year":"1990","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"9","key":"10.1002\/14651858.CD000957.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B","article-title":"Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group","volume":"44","author":"Cohen","year":"2001","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD000957.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.2008.105197","article-title":"Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study","volume":"69","author":"Jones","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/03009748609102072","article-title":"Low-dose methotrexate in rheumatoid arthritis: effect and tolerance. An open trial and a double-blind randomized study","volume":"15","author":"Szanto","year":"1986","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0019|cit19","first-page":"760","article-title":"A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis","volume":"11","author":"Thompson","year":"1984","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD000957.pub2-BIB0020|cit20","first-page":"238","article-title":"Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy","volume":"25","author":"Weinblatt","year":"1998","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0021|cit21","first-page":"epub","article-title":"Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010","volume":"Nov 27","author":"Aga","year":"2013","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0022|cit22","unstructured":"Visual Rx [Computer program]. Version 3. Dr. Christopher Cates EBM web site 2008 URL: http:\/\/www.nntonline.net"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/art.1780351003","article-title":"Use of short-term efficacy\/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A meta-analysis of published clinical trials","volume":"35","author":"Felson","year":"1992","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780360601","article-title":"The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials","volume":"36","author":"Felson","year":"1993","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","article-title":"American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis","volume":"38","author":"Felson","year":"1995","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1002\/14651858.CD000957.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0895-4356(92)90130-F","article-title":"Meta-analysis of second-line antirheumatic drugs: sample size bias and uncertain benefit","volume":"45","author":"G\u00f8tzsche","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0049-0172(83)90014-8","article-title":"Low dose oral methotrexate in rheumatoid arthritis: An uncontrolled trial and review of the literature","volume":"12","author":"Groff","year":"1983","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD000957.pub2-BIB0029|cit29","first-page":"176","article-title":"Therapeutic suppression of tissue reactivity.II. Effects of aminopterin in rheumatoid arthritis and psoriasis","volume":"221","author":"Gubner","year":"1951","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0030|cit30","first-page":"Accessed on: 09","article-title":"Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of InterventionsVersion 5.1.0 (updated March 2011)","volume":"Available from","author":"Higgins","year":"2011","journal-title":"The Cochrane Collaboration"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"2","key":"10.1002\/14651858.CD000957.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar1902","article-title":"Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure","volume":"8","author":"Kapral","year":"2006","journal-title":"Arthritis Research & Therapy"},{"issue":"S3","key":"10.1002\/14651858.CD000957.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1097\/00005650-198903001-00015","article-title":"Effect sizes for interpreting changes in health status","volume":"27","author":"Kazis","year":"1989","journal-title":"Medical Care"},{"issue":"12","key":"10.1002\/14651858.CD000957.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"878","DOI":"10.7326\/0003-4819-146-12-200706190-00009","article-title":"Ethical issues in stopping randomised trials early because of apparent benefit","volume":"146","author":"Mueller","year":"2007","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0035|cit35","first-page":"526","article-title":"Conference on Outcome Measures in Rheumatoid Arthritis Clinical Trials","volume":"20","author":"OMERACT","year":"1993","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0036|cit36","first-page":"90","article-title":"Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine","volume-title":"Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine","author":"Petitti","year":"1994"},{"issue":"CD000951","key":"10.1002\/14651858.CD000957.pub2-BIB0037|cit37","first-page":"doi: 10.1002\/14","article-title":"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis","volume":"5","author":"Shea","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"CD000951","DOI":"10.1002\/14651858.CD000951.pub2","article-title":"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis","volume":"5","author":"Shea","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD000957.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care and Research (Hoboken)"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0040|cit40","first-page":"doi: 10.1136\/an","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"Oct 25","author":"Smolen","year":"2013","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0041|cit41","first-page":"860","article-title":"Low dose methotrexate in rheumatoid arthritis","volume":"9","author":"Steinsson","year":"1982","journal-title":"Journal of Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD000957.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4081\/reumatismo.2013.207","article-title":"Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis","volume":"65","author":"Todoerti","year":"2013","journal-title":"Reumatismo"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0043|cit43","first-page":"1582\u20137","article-title":"Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results","volume":"64","author":"Heijde","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD000957.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1002\/art.23141","article-title":"Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis","volume":"56","author":"Heijde","year":"2007","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD000957.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0002-9343(85)90312-2","article-title":"Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations","volume":"79","author":"Weinstein","year":"1985","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD000957.pub2-BIB0046|cit46","first-page":"501","article-title":"Low dose pulse methotrexate therapy in rheumatoid arthritis","volume":"7","author":"Willkens","year":"1980","journal-title":"Journal of Rheumatology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD000957.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T09:34:14Z","timestamp":1711359254000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000957.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Musculoskeletal Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,10]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000957.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,10]]}}}